Recent trials unveil significant advances in cancer treatment with immunotherapy drug Tecentriq, showing a 50% reduction in cancer recurrence and death for certain colon cancer patients. Meanwhile, new studies suggest blood-thinning drugs may outperform aspirin post-heart procedures. Concerns rise over diabetes drugs' link to eye disease in long-term use.